expert roundtables

Newer Targets and Therapies for Non–Small Cell Lung Cancer
Oncology

Newer Targets and Therapies for Non–Small Cell Lung Cancer

expert roundtables
By Bruce E. Johnson, MD; Gregory J. Riely, MD, PhD; Jeffrey Crawford, MD
Multiple Sclerosis: Safety Profiles of Disease-Modifying Therapies
Neurology

Multiple Sclerosis: Safety Profiles of Disease-Modifying Therapies

expert roundtables
By Eric C. Klawiter, MD, MSc; Malcolm H. Gottesman, MD; Robert A. Bermel, MD, MBA
Emerging Therapies Add to Multiple Sclerosis Treatment Landscape
Neurology

Emerging Therapies Add to Multiple Sclerosis Treatment Landscape

expert roundtables
By Eric C. Klawiter, MD, MSc; Malcolm H. Gottesman, MD; Robert A. Bermel, MD, MBA
Initial Approach to Newly Diagnosed Patients With Chronic Myeloid Leukemia
Oncology

Initial Approach to Newly Diagnosed Patients With Chronic Myeloid Leukemia

expert roundtables
By Gabriela S. Hobbs, MD; Mark J. Levis, MD, PhD; Neil P. Shah, MD, PhD
Effectiveness of Treatments for Chronic Myeloid Leukemia: Raising the Bar
Oncology

Effectiveness of Treatments for Chronic Myeloid Leukemia: Raising the Bar

expert roundtables
By Gabriela S. Hobbs, MD; Mark J. Levis, MD, PhD; Neil P. Shah, MD, PhD
Load More